Today Pfizer/BioNTech announced that their data on the three-dose Covid-19 vaccine for children ages 6 months to under age 5 years had favorable results regarding immune response with minimal side effects.
Subscribe to:
Post Comments (Atom)
< + > CIO Podcast – Episode 122: C-Suite Executive Roles with Saad Chaudhry
For the 122nd episode of the CIO podcast hosted by Healthcare IT Today, we are joined by Saad Chaudhry, CEO at Evergreen Healthcare Partner...
No comments:
Post a Comment